First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: a multicentre study
Ouallet, Dr.J.-C. (2018a). Multiple Sclerosis and Related Disorders

Diversité des prises en charge des patients atteints de sclérose en plaques entre régions françaises
Blein, C., Chamoux, C., Reynaud, D., and Lepage, V. (2018a). Revue d’Épidémiologie et de Santé Publique (66). p.385–394

[Care pathway diversity of patients with multiple sclerosis between French regions]
Blein, C., Chamoux, C., Reynaud, D., and Lepage, V. (2018b). Rev Epidemiol Sante Publique (66). p.385–394

Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis
Hannoun, S., Kocevar, G., Durand-Dubief, F., Stamile, C., Naji, A., Cotton, F., Cavallari, M., Guttmann, C.R.G., and Sappey-Marinier, D. (2018a). Eur J Radiol (108). p.114–119

Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
Koubiyr, I., Deloire, M., Coupé, P., Dulau, C., Besson, P., Moroso, A., Planche, V., Tourdias, T., Brochet, B., and Ruet, A. (2018). Front Neurol (9).

Case Report: Acute Transverse Myelitis after Zika Virus Infection
Neri, V.C., Xavier, M.F., Barros, P.O., Melo Bento, C., Marignier, R., and Papais Alvarenga, R. (2018). Am. J. Trop. Med. Hyg.

Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study
Defer, G., de Seze, J., Bouee, S., Courouve, L., Longin, J., Payet, M., Deleglise, A.S.J., and study group (2018a). Mult Scler Relat Disord (25). p.276–281

Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure
Commowick, O., Istace, A., Kain, M., Laurent, B., Leray, F., Simon, M., Pop, S.C., Girard, P., Améli, R., Ferré, J.-C., et al. (2018). Sci Rep (8). p.13650

“Myelitis migrans”: A rare cause of treatable myelitis
Jaulent, P., Pegat, A., Grosset-Janin, C., Durand-Dubief, F., Vukusic, S., and Marignier, R. (2018a). Rev. Neurol. (Paris)

Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent, P., Hannoun, S., Kocevar, G., Rollot, F., Durand-Dubief, F., Vukusic, S., Brisset, J.-C., Sappey-Marinier, D., and Cotton, F. (2018b). Eur J Radiol (105). p.204–208

Unusual neurologic presentation of aseptic abscesses syndrome
Nicolas, P., Guerrier, O., Benoit, A., Durand-Dubief, F., Raverot, G., Debarbieux, S., Delteil, C., Vasiljevic, A., Jouanneau, E., Cotton, F., et al. (2018). Neurol Neuroimmunol Neuroinflamm (5). p.e469

Efficacité comparée du Teriflunomide et du Dimethyl-Fumarate : une étude observationnelle française multicentrique
Laplaud, D.-A., Barbin, L., Casey, R., Debouverie, M., Vukusic, S., Labauge, P., Brassat, D., Wiertlewski, S., De Seze, J., Edan, G., et al. (2018). Revue d’Épidémiologie et de Santé Publique (66). p.S201

Conventional and advanced MRI in multiple sclerosis
Louapre, C. (2018). Revue Neurologique (174). p.391–397

Organization of care for multiple sclerosis in France
Derache, N., Dufay, A., and Lebarbey, C. (2018). Rev. Neurol. (Paris) (174). p.475–479

Organization of healthcare in multiple sclerosis
Gignoux, L. (2018). Rev. Neurol. (Paris) (174). p.471–474

Diagnostic value of 3DFLAIR in clinical practice for the detection of infratentorial lesions in multiple sclerosis in regard to dual echo T2 sequences
Hannoun, S., Heidelberg, D., Hourani, R., Nguyen, T.T.T., Brisset, J.-C., Grand, S., Kremer, S., Bonneville, F., Guttmann, C.R.G., Dousset, V., et al. (2018b). Eur J Radiol (102). p.146–151

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Cobo-Calvo, A., Ruiz, A., Maillart, E., Audoin, B., Zephir, H., Bourre, B., Ciron, J., Collongues, N., Brassat, D., Cotton, F., et al. (2018). Neurology

Oligoclonal Bands in Spinal Fluid Improve the Specificity of Different MRI Criteria for Dissemination in Space to Predict a First Clinical Event in Children with the Radiologically Isolated Syndrome (S51.002)
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brenton, J.N., Brassat, D., Carra-Dalliere, C., Seze, J.D., Dubief, F.D., et al. (2018). Neurology (90). p.S51.002

Efficacité et sécurité d’emploi de l’alemtuzumab à 2 ans : retour sur 150 patients français
Ayrignac, X., De Seze, J., Vukusic, S., Brassat, D., Laplaud, D., Lebrun-Frénay, C., and Labauge, P. (2018). Revue Neurologique (174). p.S155

Formes atypiques de sclérose en plaques et autres affections inflammatoires démyélinisantes idiopathiques du système nerveux central : étude nationale sur 88 cas
Codjia, P., Ayrignac, X., Carra-Dallière, C., Durand-Dubief, F., De Seze, J., Lebrun-Frenay, C., and Labauge, P. (2018). Revue Neurologique (174). p.S100–S101

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Hacohen, Y., Wong, Y.Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., Kalser, J., Poulat, A.L., Maurey, H., Ganelin-Cohen, E., et al. (2018). JAMA Neurol (75). p.478–487

Controverse : les traitements de fond modifient-ils le passage en forme secondairement progressive ? Synthèse
Ouallet, J.-C. (2018b). Revue Neurologique (174). p.S180–S181

Landscape of MS patient cohorts and registries: Recommendations for maximizing impact
Bebo, B.F., Fox, R.J., Lee, K., Utz, U., and Thompson, A.J. (2018). Mult Scler (24). p.579–586

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Cabre, P., Mejdoubi, M., Jeannin, S., Merle, H., Plumelle, Y., Cavillon, G., Smadja, D., Marignier, R., and Francophone Society of Multiple Sclerosis and OFSEP investigators (2018). J. Neurol. (265). p.917–925

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial
Defer, G., Le Caignec, F., Fedrizzi, S., Montastruc, F., Chevanne, D., Parienti, J.-J., and Peyro-Saint-Paul, L. (2018b). Trials (19).

Weekly follow up of acute lesions in three early multiple sclerosis patients using MR spectroscopy and diffusion
Kocevar, G., Stamile, C., Hannoun, S., Roch, J.-A., Durand-Dubief, F., Vukusic, S., Cotton, F., and Sappey-Marinier, D. (2018). J Neuroradiol (45). p.108–113

Cervical spinal cord atrophy
Zeydan, B., Gu, X., Atkinson, E.J., Keegan, B.M., Weinshenker, B.G., Tillema, J.-M., Pelletier, D., Azevedo, C.J., Lebrun-Frenay, C., Siva, A., et al. (2018). Neurol Neuroimmunol Neuroinflamm (5).

Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients
Calocer, F., Dejardin, O., Droulon, K., Launoy, G., and Defer, G. (2018). PLoS ONE (13). p.e0191646

Caractéristique de la cohorte française des syndromes radiologiques isolés (RIS)
Christine Lebrun-Frénay, R., Céline Callier, Patrick Vermersch, Caroline Papeix, Emmanuelle Le Page, Françoise Durand-Dubief, Pierre Labauge, OFSEP, SFSEP (2018). Revue Neurologique (5961). p.S2–S200

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
Ciron, J., Audoin, B., Bourre, B., Brassat, D., Durand-Dubief, F., Laplaud, D., Maillart, E., Papeix, C., Vukusic, S., Zephir, H., et al. (2018). Rev. Neurol. (Paris) (174). p.255–264

The first MICCAI challenge on PET tumor segmentation
Hatt, M., Laurent, B., Ouahabi, A., Fayad, H., Tan, S., Li, L., Lu, W., Jaouen, V., Tauber, C., Czakon, J., et al. (2018). Med Image Anal (44). p.177–195

Demyelinating diseases
Lebrun, C., and de Seze, J. (2018). Rev. Neurol. (Paris) (174). p.355

Quelle utilisation des traitements de fond chez des patients ayant une SEP rémittente en France sur la période 1990–2017 ? Éléments de réponse à partir des données de l’Ofsep
Leray, E., Rollot, F., Casey, R., Roux, J., De Seze, J., Laplaud, D., and Vukusic, S. (2018). Revue Neurologique (5961). p.S2–S200

Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
Perriot, S., Mathias, A., Perriard, G., Canales, M., Jonkmans, N., Merienne, N., Meunier, C., El Kassar, L., Perrier, A.L., Laplaud, D.-A., et al. (2018). Stem Cell Reports (11). p.1199–1210